The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A.
Abstract
Efforts to change the fate of human hematopoietic stem cells (HSCs) and progenitor cells (HPCs) in vitro have met with limited success. We hypothesized that previously utilized in vitro conditions might result in silencing of genes required for the maintenance of primitive HSCs/HPCs. DNA methylation and histone deacetylation are components of an epigenetic program that regulates gene expression. Using pharmacologic agents in vitro that might possibly interfere with DNA methylation and histone deacetylation, we attempted to maintain and expand cells with phenotypic and functional characteristics of primitive HSCs/HPCs. Human marrow CD34(+) cells were exposed to a cytokine cocktail favoring differentiation in combination with 5aza 2'deoxycytidine (5azaD) and trichostatin A (TSA), resulting in a significant expansion of a subset of CD34(+) cells that possessed phenotypic properties as well as the proliferative potential characteristic of primitive HSCs/HPCs. In addition, 5azaD- and TSA-pretreated cells but not the CD34(+) cells exposed to cytokines alone retained the ability to repopulate immunodeficient mice. Our findings demonstrate that 5azaD and TSA can be used to alter the fate of primitive HSCs/HPCs during in vitro culture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, treatment of normal hematopoietic stem cells with HDAC inhibitors has the opposite effect, maintaining self-renewal,44,48–50 possibly by preventing repression of stem cell genes by differentiation stimuli.44”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [48]
In the citing paper
“The DNA hypomethylating drug decitabine maintains normal hematopoietic stem cell (HSC) self-renewal but induces terminal differentiation in acute myeloid leukemia (AML) cells.”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [6]
In the citing paper
“In contrast, in normal HSC which do not express high levels of lineage-specifying TF, DNMT1 depletion prevents stem cell gene repression by differentiation stimuli, thereby maintaining stem cell phenotype (6–15).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [6]
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Epigenetic Reprogramming in Mammalian Development
Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078 · cited 1×
“Since the increase in the CD34 CD90 cell number was similar when one combined the resultant cellular products of the cultures initiated with subpopulations of CD34 cells treated to that observed in cultures of unfractionated CD34 cell population, the increase in CD34 CD90 cells could be accounted for by 2 simultaneous…”
BackgroundCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
The Role of DNA Methylation in Mammalian Epigenetics
Jones, P. A., & Takai, D. (2001) · Science · doi:10.1126/science.1063852 · Cited by 2,070
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & Melton, D. A. (2002) · Science · doi:10.1126/science.1072530 · Cited by 1,709
Determination of lymphocyte division by flow cytometry
Lyons, A. B., & Parish, C. R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90236-4 · Cited by 1,657
Research works printed but not linked: 2
- Cross MA, Enver T. The lineage commitment of haematopoietic progenitor cells. Curr Opin Genet Dev. 1997;5: 609-613.
- Danet G, Lee H, Luongo J, et al. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion. Exp Hematol. 2001;29: 1465-1473. · DOI
Cited by
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-05-1693 · Cited by 398
Ravandi, F., Alattar, M. L., Grunwald, M. R., Rudek, M. A., Rajkhowa, T., Richie, M. A., Pierce, S., Daver, N., Garcia-Manero, G., Faderl, S., et al. (2013) · Blood · doi:10.1182/blood-2013-01-480228 · Cited by 381
“Median percentage blasts in BM [range] 66 [2-98]”
BackgroundIn Vitro Differentiation of Embryonic and Adult Stem Cells into Hepatocytes: State of the Art
Snykers, S., De Kock, J., Rogiers, V., & Vanhaecke, T. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0963 · Cited by 251
Metadata
- Authors
- Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R.
- Affiliations
- University of Illinois Chicago (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-06-01
- Volume
- 103
- Issue
- 11
- Pages
- 4102-4110
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2005852731
- Cited by
- 195
- References
- 41
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 11 · 2016: 7 · 2015: 16 · 2014: 10 · 2013: 8 · 2012: 12
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, hematopoietic progenitor cells, decitabine, trichostatin A, DNA methylation, histone deacetylation, epigenetic reprogramming, CD34+ cells, in vitro expansion, repopulation
- MeSH terms
- Decitabine, Adult, Antimetabolites, Antineoplastic, Azacitidine, Cell Division, Cells, Cultured, Hematopoietic Stem Cells, Humans, Hydroxamic Acids, Methylation, Phenotype, Protein Synthesis Inhibitors, Thy-1 Antigens, Antigens, CD34, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A. https://app.cochat.ai/papers/10.1182/blood-2003-07-2431
- The paper
- Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R. (2004). Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A. Blood. https://doi.org/10.1182/blood-2003-07-2431
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.